1. Home
  2. POWI vs LQDA Comparison

POWI vs LQDA Comparison

Compare POWI & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POWI
  • LQDA
  • Stock Information
  • Founded
  • POWI 1988
  • LQDA 2004
  • Country
  • POWI United States
  • LQDA United States
  • Employees
  • POWI N/A
  • LQDA N/A
  • Industry
  • POWI Semiconductors
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • POWI Technology
  • LQDA Health Care
  • Exchange
  • POWI Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • POWI 2.6B
  • LQDA 2.5B
  • IPO Year
  • POWI 1997
  • LQDA 2018
  • Fundamental
  • Price
  • POWI $44.07
  • LQDA $26.48
  • Analyst Decision
  • POWI Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • POWI 3
  • LQDA 9
  • Target Price
  • POWI $61.67
  • LQDA $32.11
  • AVG Volume (30 Days)
  • POWI 541.7K
  • LQDA 2.4M
  • Earning Date
  • POWI 11-05-2025
  • LQDA 08-12-2025
  • Dividend Yield
  • POWI 1.85%
  • LQDA N/A
  • EPS Growth
  • POWI N/A
  • LQDA N/A
  • EPS
  • POWI 0.59
  • LQDA N/A
  • Revenue
  • POWI $442,468,000.00
  • LQDA $19,322,000.00
  • Revenue This Year
  • POWI $11.06
  • LQDA $362.31
  • Revenue Next Year
  • POWI $14.36
  • LQDA $418.29
  • P/E Ratio
  • POWI $76.82
  • LQDA N/A
  • Revenue Growth
  • POWI 7.16
  • LQDA 30.20
  • 52 Week Low
  • POWI $39.53
  • LQDA $9.30
  • 52 Week High
  • POWI $69.53
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • POWI 40.16
  • LQDA 55.49
  • Support Level
  • POWI $43.97
  • LQDA $27.15
  • Resistance Level
  • POWI $46.24
  • LQDA $29.43
  • Average True Range (ATR)
  • POWI 1.26
  • LQDA 1.18
  • MACD
  • POWI 0.17
  • LQDA -0.55
  • Stochastic Oscillator
  • POWI 28.75
  • LQDA 12.55

About POWI Power Integrations Inc.

Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: